Robert Kim currently serves as Chief Medical Officer at Character Biosciences since September 2025, previously holding the same position at 4D Molecular Therapeutics from October 2020 to August 2025. Kim has extensive experience in clinical research and development, including roles as Senior Vice President at 4D Molecular Therapeutics, Chief Medical Officer at ViewPoint Therapeutics and Apellis Pharmaceuticals, and Chief Medical Officer and EVP of Research and Development at Vision Medicines. Additionally, Kim was Vice President at Alcon Laboratories and GlaxoSmithKline, and held various leadership positions at Novartis Institutes for BioMedical Research and Genentech. In academia, Kim served as Associate Clinical Professor at UCSF School of Medicine from 1994 to 2025. Academically, Kim holds degrees from Brown University, the University of California, San Francisco, and an MBA from the University of California, Berkeley, along with a fellowship from Moorfields Eye Hospital in London.
This person is not in any teams
This person is not in any offices